Navigation Links
Duska Therapeutics Receives Comments From FDA on Phase 3 ATPace(TM) Protocol Synopsis
Date:8/12/2008

treatment of heart failure. In addition, Duska has a preclinical program to develop new chemical entities that target a newly discovered pathway in the pathophysiology of chronic obstructive pulmonary disease. For more information, visit http://www.duskatherapeutics.com.

Forward-looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended that involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements. The forward-looking statements are based on current expectations, estimates and projections made by management. Duska intends for the forward-looking statements to be covered by the safe harbor provisions for forward-looking statements. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," or variations of such words are intended to identify such forward-looking statements. All statements in this release regarding the future outlook related to Duska are forward-looking statements, including the statements that Duska plans to submit the revised Phase 3 clinical trial to the FDA for Special Protocol Assessment (SPA) procedure approval, Duska believes that the initial dose of ATPace(TM) will be significantly more efficacious than the initial labeled dose of adenosine in terminating PSVT, ATP is believed to have dual inhibitory action; one mediated by adenosine, the product of its rapid enzymatic degradation, and the other, a triggered vagal reflex, Duska intends to initiate a single, prospective, placebo-controlled, and randomized trial in patients presenting to the emergency room with PSVT to demonstrate ATPace's clinical safety and efficacy, Duska intends to file a New Drug Application under section 505(b)(2), Dr. Amir Pelleg believes that the comments of
'/>"/>

SOURCE Duska Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Duska Therapeutics Plans 505(b)(2) NDA Filing Route for ATPace(TM)
2. Duska Therapeutics Sponsored University of Pennsylvania Study Demonstrates ATP Improves Sperm Motility and In Vitro Fertilization in Animals
3. Prime Therapeutics Receives TIPPS Certification
4. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
5. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
6. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
7. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
8. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
9. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
10. Prime Therapeutics Announces URAC Accreditation
11. Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... safe and sound is one of the best Halloween treats ... and goody bags have reflective strips that improve visibility to ... Meadowlands Hospital Medical Center in Secaucus, N.J. Trick-or-treaters ... Davis said. He offers these others tips: ... small area of skin first to ensure it doesn,t cause ...
(Date:10/25/2014)... Background: , In 1998 Bob Savage founded the Connecticut ... the field of establishing recovery community organizations. Bob had ... he retired, he set out to answer a couple questions ... , 1. Where are the people in recovery when ... Can the recovery community be organized to advocate for issues ...
(Date:10/25/2014)... Minnesota (PRWEB) October 25, 2014 ... testing firm which verifies IT-accessibility for disabled users ... Access Approved® logo to Mackin Educational Resources ... digital resource management system and to the Minnesota ... the "Own Best Medicine" website. ...
(Date:10/25/2014)... QueenBeeTickets.com has a variety of tickets for ... prices. Bob Seger & The Silver Bullet Band tickets ... are going on sale October 25 and are expected ... browse the selection of tickets for Bob Seger & ... singer is touring North America beginning next month, and ...
(Date:10/25/2014)... New York, New York (PRWEB) October 25, 2014 ... of transvaginal mesh lawsuits ( http://www.vaginalmeshlawsuit2015.com/ ) ... multidistrict litigation underway in U.S. District Court, Southern ... Motion for Summary Judgment on Punitive Damages in ... Florida plaintiffs. In a ruling issued on October ...
Breaking Medicine News(10 mins):Health News:Tips for Safe Trick-or-Treating 2Health News:CCAR Accepting Nominations for the Bob Savage Recovery Advocate of the Year Award 2Health News:IT-Accessibility Award Granted to Education and Health Care for Section 508/WCAG 2Health News:IT-Accessibility Award Granted to Education and Health Care for Section 508/WCAG 3Health News:QueenBeeTickets.com Features Bob Seger & The Silver Bullet Band Tickets for Charleston Civic Center, Huntington Center, and Nationwide Arena at Reduced Prices 2Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 4
... Association (PCMA) issued the following response to today,s,statement ... "PCMA member companies have routinely paid clean claims ... so. Before rushing to judgment,on the issue of ... an,independent study to explore this issue generally and ...
... the brain that support memory function differs between people ... pressure, and this difference seems to increase when high ... at the American Heart Associations 61st Annual Fall Conference ... does not mean that those with high blood pressure ...
... Insurance Industry Proposal Is ,Bad Public Policy, ... health courts by Case Western Reserve University professors ... would be burdensome,prohibitively expensive and would come at ... prepared under a grant from the American Association ...
... North Carolina,students interested in earning the doctor of optometry ... on,Optometry sponsored by the N.C. State Education Assistance Authority.,Conferences are ... Carolina State University (Raleigh, NC) - 1 pm - 5 ... Carolina State University in the Talley Student ...
... protects against blood loss, study finds , , THURSDAY, Sept. ... to the rescue of trauma victims suffering from heavy ... suggests. , "This is the first scientific study showing ... study author Dr. Marie-Pierre Poloujadoff, an emergency physician at ...
... KALAMAZOO, Mich., Sept. 27 Stryker,Corporation (NYSE: ... a resolution,with the United States Attorney,s office in ... consulting practices in the,orthopaedic industry. The investigation began ... March 2005 that requested documents for the,period January ...
Cached Medicine News:Health News:Memory tasks require more coordinated brain blood flow for people with high blood pressure 2Health News:Memory tasks require more coordinated brain blood flow for people with high blood pressure 3Health News:New Report Says 'Health Courts' Bureaucracies Offer Big Financial Burdens and Loss of Patient Rights 2Health News:Optometry Career Conferences Set for Five N.C. Campuses in October 2Health News:Toxic Shock Drug Might Aid Trauma Victims 2Health News:Toxic Shock Drug Might Aid Trauma Victims 3Health News:Stryker Announces Resolution Related to March 2005 U.S. Department of Justice Subpoena 2
(Date:10/22/2014)... Mass. , Oct. 22, 2014 InVivo ... Cambridge, MA is revolutionizing spinal cord injury ... has been shown to outperform in tissue regrowth in ... the scaffold.  Made from an FDA approved polymer, the ... making it harmless to the human body. NVIV has ...
(Date:10/22/2014)... , Oct. 22, 2014 WHEN: Wednesday, October ... complimentary registration available at: http://bit.ly/1yStiU9 ... Vidyasekar and Visionary Innovation Research Group Senior ... electricity, self-assembling materials, nanobots and flexible electronics ... will transform our lives in the coming ...
(Date:10/22/2014)... -- Provectus Biopharmaceuticals, Inc. (NYSEMKT: PVCT) specializes in developing ... for cancer, is designed for injection into solid tumors ... focus is on melanoma, breast cancer and cancers of ... PV-10 as a therapy for metastatic melanoma, and of ... psoriasis. This summer, the Company signed ...
Breaking Medicine Technology:InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 2InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 3Futuristic Technologies That Will Transform Our World Beyond 2030 2Futuristic Technologies That Will Transform Our World Beyond 2030 3Futuristic Technologies That Will Transform Our World Beyond 2030 4Provectus Biopharmaceuticals Looks at the Asian Markets: Analyst Coverage by Small Cap Traders 2
... 8, 2011 The Amerigroup Foundation recently announced that ... Partnership to benefit the Rockbridge Area Free Clinic. ... works to provide uninsured Virginians with access to medication ... access and distribute free bulk prescription medications to 20 ...
... BOTHELL, Wash., July 8, 2011 Cardiac Science ... ( AED s) and diagnostic cardiac monitoring ... Labor, and Welfare approved a new model of its ... Healthcare to distribute its AEDs in Japan. Japan-based Omron ...
Cached Medicine Technology:Amerigroup Foundation Presents Grant to Rx Partnership 2Cardiac Science Gains Japanese Regulatory Approval for Powerheart AED 2Cardiac Science Gains Japanese Regulatory Approval for Powerheart AED 3Cardiac Science Gains Japanese Regulatory Approval for Powerheart AED 4
2 tests on one meter. Glucose test for immediate glucose levels. GlucoProtein (Fructosamine) for overall control, average over prior 2-3 weeks. The Duet is the only hand held instrument to perform th...
... ICON®microALB is a qualitative immunoassay for ... of kidney disease. This albumin specific, CLIA ... mg/L and specificity of 95%, and gives ... stable viewing results up to 8 hours. ...
... here! LTF™ (Layered Thin Film) technology is ... that is easy to read, extremely precise ... credit card. What is Infectious Vaginitis? Infectious ... visit their physician. Vaginal discharge and odor ...
... Screen Tests are available in 14 configurations ... Designed using Microgenics Antibody Technology, the SureStep™ ... of care immunoassay targeted to detect MDMA ... and MDEA but no cross-reactivity to any ...
Medicine Products: